Compugen | CGEN - Spese Operative





Spese Operative Cambiamento Data
Arca Biopharma USD 34.43M 326K 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Bio Path USD 488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
Minerva Neurosciences USD 4.52M 155.46K 2024-12
RedHill Biopharma USD 5.51M 1.08M 2024-06
TherapeuticsMD USD 1.41M 50K 2024-06